About Inito

Inito develops a fertility monitoring device that measures four key hormones—Estrogen, LH, PdG, and FSH—using a single test strip to provide precise numerical values of fertility status. This technology enables users to accurately track their ovulation and fertile days, addressing the limitations of traditional ovulation tests that often yield ambiguous results.

```xml <problem> Traditional ovulation tests often provide ambiguous "yes/no" results based on a single hormone, failing to confirm actual ovulation or provide a comprehensive understanding of a woman's cycle. This can be particularly challenging for women with irregular cycles or conditions like PCOS, making it difficult to pinpoint fertile days and optimize conception efforts. </problem> <solution> Inito is a fertility monitoring system that measures four key hormones—Estrogen, Luteinizing Hormone (LH), Progesterone metabolite (PdG), and Follicle-Stimulating Hormone (FSH)—using a single-use test strip and a smartphone-connected monitor to provide quantitative hormone values. The system tracks up to six fertile days and confirms ovulation by measuring PdG levels, providing a more complete picture of a woman's cycle. Users receive personalized fertility assessments and hormone charts directly on their smartphone via a companion app, enabling them to identify their fertile window and confirm successful ovulation. </solution> <features> - Measures Estrogen, LH, PdG, and FSH on a single test strip for a comprehensive fertility assessment - Provides numerical hormone values, unlike traditional ovulation tests that only give "yes/no" results - Confirms ovulation by measuring PdG (urine metabolite of progesterone) - Tracks up to 6 fertile days per cycle - Personalized results tailored to individual hormone levels, accommodating regular and irregular cycles - Companion app provides hormone charts, testing reminders, and ovulation confirmation - HSA/FSA eligibility for purchase - Monitor connects to iPhone devices for easy data capture and analysis </features> <target_audience> The primary target audience includes women who are trying to conceive, especially those with irregular cycles or conditions like PCOS, and who seek a more accurate and comprehensive understanding of their fertility. </target_audience> <revenue_model> The company generates revenue through the sale of the Inito Fertility Monitor starter kit and recurring sales of test strip refill packs. A Black Friday promotion offered the starter kit for $99, reduced from $149. </revenue_model> ```

What does Inito do?

Where is Inito located?

Inito is based in Palo Alto, United States.

When was Inito founded?

Inito was founded in 2015.

How much funding has Inito raised?

Inito has raised $13.5M.

Location

Palo Alto, United States

Founded

2015

Funding

$13.5M

Employees

162 employees

Investors

Fireside Ventures Y Combinator z21 Ventures Biifund Owlcapital

Inito

Relative Traction Score based on online presence metrics compared to companies in the same age group.

Inito

Relative Traction Score based on online presence metrics compared to companies in the same age group.

Executive Summary

inito.com 30K+

Founded 2015 – Palo Alto, United States

Funding

No specific funding rounds found.

Total Funding

$13.5M

Backed by

BiifundFireside VenturesIKP Knowledge ParkOwlcapital…

Team (100+)

No team information available.

Company Description

Problem

Traditional ovulation tests often provide ambiguous "yes/no" results based on a single hormone, failing to confirm actual ovulation or provide a comprehensive understanding of a woman's cycle. This can be particularly challenging for women with irregular cycles or conditions like PCOS, making it difficult to pinpoint fertile days and optimize conception efforts.

Solution

Inito is a fertility monitoring system that measures four key hormones—Estrogen, Luteinizing Hormone (LH), Progesterone metabolite (PdG), and Follicle-Stimulating Hormone (FSH)—using a single-use test strip and a smartphone-connected monitor to provide quantitative hormone values. The system tracks up to six fertile days and confirms ovulation by measuring PdG levels, providing a more complete picture of a woman's cycle. Users receive personalized fertility assessments and hormone charts directly on their smartphone via a companion app, enabling them to identify their fertile window and confirm successful ovulation.

Features

Measures Estrogen, LH, PdG, and FSH on a single test strip for a comprehensive fertility assessment

Provides numerical hormone values, unlike traditional ovulation tests that only give "yes/no" results

Confirms ovulation by measuring PdG (urine metabolite of progesterone)

Tracks up to 6 fertile days per cycle

Personalized results tailored to individual hormone levels, accommodating regular and irregular cycles

Companion app provides hormone charts, testing reminders, and ovulation confirmation

HSA/FSA eligibility for purchase

Monitor connects to iPhone devices for easy data capture and analysis

Target Audience

The primary target audience includes women who are trying to conceive, especially those with irregular cycles or conditions like PCOS, and who seek a more accurate and comprehensive understanding of their fertility.

Revenue Model

The company generates revenue through the sale of the Inito Fertility Monitor starter kit and recurring sales of test strip refill packs. A Black Friday promotion offered the starter kit for $99, reduced from $149.

Sources: